Furthermore, no significant correlation was observed between the BCR–ABL1 transcript and SKP2 gene expression levels in the CML patients in the present study, suggesting that the SKP2 gene might be associated with BCR–ABL1-independent resistance to IM. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.